Skip to content

MapLight Therapeutics, Inc. MPLT Tax on Share Settlement

Tax on Share Settlement at other companies

MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$5.96M+116%
Alto Neuroscience logo
Alto NeuroscienceANRO
$190K
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$2.64M
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$301K-53.1%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$12.92M+981%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.39B+100%
Enterprise value$1.34B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's tax on share settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's tax on share settlement?
MapLight Therapeutics, Inc. (MPLT) reported tax on share settlement of $7.5M in Q1 2026.
What does tax on share settlement mean?
Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.